Related Experiment Video
Updated: Nov 10, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
ADAMTS9-AS2: A Functional Long Non-coding RNA in Tumorigenesis
Wen Xu1, Bei Wang1, Yuxuan Cai1
1College of Medical Science, China Three Gorges University, Yichang 443002, China.
Background:
Long non-coding RNAs (lncRNA) have been identified as novel molecular regulators in cancers. LncRNA ADAMTS9-AS2 can mediate the occurrence and development of cancer through various ways, such as regulating miRNAs, activating the classical signaling pathways in cancer, and so on, which have been studied by many scholars. In this review, we summarize the molecular mechanisms of ADAMTS9-AS2 in different human cancers.
Methods:
Through a systematic search of PubMed, lncRNA ADAMTS9-AS2 mediated molecular mechanisms in cancer are summarized inductively.
Results:
ADAMTS9-AS2 aberrantly expression in different cancers is closely related to cancer proliferation, invasion, migration, and inhibition of apoptosis. The involvement of ADAMTS9-AS2 in DNA methylation, mediating PI3K / Akt / mTOR signaling pathways, and regulating miRNAs and proteins, shows its significant potential as a therapeutic cancer target.
Conclusion:
LncRNA ADAMTS9-AS2 can become a promising biomolecular marker and a therapeutic target for human cancer.
Insights
Long non-coding RNA ADAMTS9-AS2 plays a key role in cancer development by influencing cell proliferation, invasion, and apoptosis. This lncRNA shows promise as a diagnostic biomarker and therapeutic target for various human cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are emerging as critical regulators in cancer biology.
- LncRNA ADAMTS9-AS2 has been implicated in various cancer processes.
- Understanding its molecular mechanisms is crucial for cancer research.
Purpose of the Study:
- To review and summarize the molecular mechanisms of lncRNA ADAMTS9-AS2 in human cancers.
- To highlight the role of ADAMTS9-AS2 in cancer occurrence and progression.
- To consolidate current knowledge on ADAMTS9-AS2's functions in oncology.
Main Methods:
- Systematic literature search of PubMed database.
- Inductive summarization of research findings.
- Focus on molecular mechanisms mediated by lncRNA ADAMTS9-AS2 in cancer.
Main Results:
- Aberrant expression of ADAMTS9-AS2 correlates with cancer proliferation, invasion, migration, and apoptosis inhibition.
- ADAMTS9-AS2 is involved in DNA methylation and PI3K/Akt/mTOR signaling pathways.
- It also regulates microRNAs (miRNAs) and protein expression in cancer cells.
Conclusions:
- LncRNA ADAMTS9-AS2 demonstrates significant potential as a therapeutic target for cancer.
- ADAMTS9-AS2 can serve as a promising biomarker for human cancer diagnosis and prognosis.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Abnormal Proliferation
